X0303 4 2010-07-27 1 0000704328 SOMANETICS CORP smts 0001245083 AUSMAN JAMES I 1 0 0 0 Common Shares 2010-07-27 4 U 0 27785 25 D 0 D Director stock option (right to buy) 2.32 2010-07-27 4 D 0 2000 22.68 D 2001-02-22 2011-02-22 Common Shares 2000 0 D Director stock option (right to buy) 2.95 2010-07-27 4 D 0 3500 22.05 D 2002-05-10 2012-05-10 Common Shares 3500 0 D Director stock option (right to buy) 2.8 2010-07-27 4 D 0 3500 22.2 D 2003-04-10 2013-04-10 Common Shares 3500 0 D Director stock option (right to buy) 12 2010-07-27 4 D 0 3500 13 D 2004-03-30 2014-03-30 Common Shares 3500 0 D Director stock option (right to buy) 14.92 2010-07-27 4 D 0 10000 10.08 D 2005-11-30 2015-05-04 Common Shares 10000 0 D Director stock option (right to buy) 18.06 2010-07-27 4 D 0 10000 6.94 D 2016-06-29 Common Shares 10000 0 D Director sotck option (right to buy) 19.33 2010-07-27 4 D 0 10000 5.67 D 2017-06-13 Common Shares 10000 0 D Director stock option (right to buy) 16.82 2010-07-27 4 D 0 10000 8.18 D 2018-04-10 Common Shares 10000 0 D Director stock option (right to buy) 14.77 2010-07-27 4 D 0 10000 10.25 D 2019-04-23 Common Shares 10000 0 D The option vested in five equal annual installments beginning on 6/29/07 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010 The option vested in five equal annual installments beginning on 6/13/08 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010 The option vested in five equal annual installments beginning on 4/10/09 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010 The option vested in five equal annual installments beginning on 4/23/10 and the unvested portion of the option became exercisable upon change of control pursuant to acceptance of the shares in the tender offer pursuant to the agreement and plan of merger between Somanetics and Covidien announced on June 16, 2010 James I. Ausman 2010-07-28